ASCEND BY NTHRYS
Research Abroad Products

Translational Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 73–84 of 200 project topics
Pharmacogenomics Testing and Precision Medicine Workflow Software
End-to-end SaaS platforms that integrate pharmacogenomic testing, drug interaction databases, and personalized dosing recommendations into clinical workflows. This market addresses the $15+ billion precision medicine opportunity by enabling providers to monetize patient-specific medication optimization services.
Translational Genomics Market Intelligence Click to view more details →
Cancer Genomics Profiling and Tumor Mutation Burden Analytics
Commercial platforms that sequence tumor genomes, identify actionable mutations, and calculate tumor mutation burden (TMB) for immunotherapy patient stratification. Oncology centers generate $2,000-5,000 per test in billable revenue while improving treatment outcomes and clinical trial enrollment.
Translational Genomics Market Intelligence Click to view more details →
Polygenic Risk Score Calculation and Population Health Management
Cloud-based tools that compute polygenic risk scores for complex diseases and integrate them into population health screening programs and insurance risk models. Insurers and health systems deploy these platforms to identify high-risk cohorts, reducing claims costs and generating $10-50 million in annual economic value.
Translational Genomics Market Intelligence Click to view more details →
Whole Genome Sequencing Data Management and Compliance Platforms
Enterprise software solutions that manage petabyte-scale genomic datasets while ensuring HIPAA, GDPR, and regulatory compliance across clinical and research environments. These platforms command $500K-2M annual contracts by reducing data breach risk and enabling secure data monetization partnerships.
Translational Genomics Market Intelligence Click to view more details →
Liquid Biopsy Genomics Analysis and Circulating Tumor DNA Detection
Specialized bioinformatics platforms that analyze cell-free DNA and circulating tumor DNA (ctDNA) from blood samples for early cancer detection and minimal residual disease monitoring. Companies commercializing these tools capture $5,000-15,000 per test and address a $20+ billion market opportunity in non-invasive diagnostics.
Translational Genomics Market Intelligence Click to view more details →
Rare Disease Gene Matching and Patient-Researcher Network Solutions
Commercial platforms that match undiagnosed patients with genetic variants to research cohorts, clinical trials, and gene therapy opportunities through proprietary databases. These B2B2C marketplaces generate revenue through trial enrollment fees, patient licensing, and pharmaceutical partnerships.
Translational Genomics Market Intelligence Click to view more details →
Genomic Biomarker Discovery and Clinical Assay Development Services
Full-service commercial offerings that identify novel genomic biomarkers using machine learning, validate them, and develop FDA-cleared clinical assays for diagnostics companies. Service providers capture 30-50% gross margins while generating $5-20M contracts from pharmaceutical and diagnostic manufacturers.
Translational Genomics Market Intelligence Click to view more details →
Real-World Genomic Evidence and Outcomes Analytics for Payers
Analytics platforms that aggregate genomic data with claims, EHR, and outcomes data to demonstrate clinical and economic value of genetic testing and precision therapies. Payers and pharmaceutical companies purchase these insights at $2-5M annually to make reimbursement decisions and optimize therapy economics.
Translational Genomics Market Intelligence Click to view more details →
Genomic Variant Interpretation SaaS Platform
A cloud-based software platform that automates the classification and clinical significance assessment of genetic variants using machine learning and curated databases. This tool enables clinical laboratories and diagnostic companies to accelerate report turnaround times and reduce manual interpretation costs by up to 60%.
Translational Genomics Investment Analytics Click to view more details →
Precision Medicine Patient Stratification Analytics Engine
An enterprise analytics solution that processes whole-genome sequencing data to identify patient subpopulations for targeted drug response and treatment selection. Pharmaceutical companies and healthcare providers monetize this through improved clinical trial enrollment, personalized therapy recommendations, and reduced adverse event rates.
Translational Genomics Investment Analytics Click to view more details →
Liquid Biopsy Biomarker Discovery and Validation Platform
A proprietary software and wet-lab service that identifies circulating tumor DNA and protein biomarkers from blood samples for early cancer detection and monitoring. This generates recurring revenue through companion diagnostic licensing, clinical lab partnerships, and direct-to-consumer health screening services.
Translational Genomics Investment Analytics Click to view more details →
Multi-Omic Data Integration and Interpretation Tools
Software tools that consolidate and analyze genomics, transcriptomics, proteomics, and metabolomics data to reveal comprehensive disease mechanisms and therapeutic targets. Contract research organizations and biotech firms leverage this for drug discovery acceleration, reducing development timelines by 18-24 months.
Translational Genomics Investment Analytics Click to view more details →